EUVIMEDEUVIMED entdecken
Crossref

The Efficacy of Antibiotic Combination Therapies with Fosfomycin For Multi-Drug Resistant Gram-Negative Bacterial Infections

Elif Nur Özbay Haliloğlu, Güle Çınar, Kemal Osman Memikoğlu

Ankara Üniversitesi Tıp Fakültesi Mecmuası · 27.03.2026 · 79 (1) · 72-81

DOI: 10.65092/autfm.1779034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Ankara Üniversitesi Tıp Fakültesi Mecmuası, online erschienen am 27.03.2026. Verfasst von Elif Nur Özbay Haliloğlu und 2 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Antimicrobial resistance in Gram-negative bacteria especially infections due to multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan drug-resistant (PDR) strains has narrowed therapeutic options. In the absence of many new agents, older antibiotics are being reconsidered in combination regimens. Fosfomycin, with a unique mechanism and broad spectrum, is a leading candidate in this context.

Objective

To assess whether parenteral fosfomycin-based combinations influence mortality and morbidity in hospitalized adults with MDR/XDR/PDR Gramnegative infections.

Methods

We conducted a retrospective study of adults treated between February 2019 and June 2020 in university hospital ICUs and wards. Patients received either combination therapy including IV fosfomycin (n=141) or combination therapy without fosfomycin (n=137). Demographic, clinical, laboratory and treatment data were extracted from the hospital information system.

Results

Baseline age, sex, APACHE II and SOFA scores were similar between groups, whereas the fosfomycin group had a higher Charlson comorbidity index. No significant difference was observed in 28-day or 60-day mortality between fosfomycin and control groups (p=0.568 and p=0.094, respectively); point estimates favored the fosfomycin group (28-day mortality 41.1% vs 44.5%). Mortality correlated with higher illness severity and invasive device use in both groups. Ten patients receiving fosfomycin developed hypernatremia.

Conclusion

In patients with high illness severity, comorbidity, and invasive device needs, fosfomycin-containing combinations, when used with suitable companion agents and accompanied by careful safety monitoring, constitute a rational treatment option against MDR/XDR/PDR Gram-negative infections. Pharmacokinetic (PK) and pharmacodynamic (PD) data and well-designed clinical studies are required to clarify clinical efficacy and safety.

Zitieren

APA

Haliloğlu, E. N. Ö., Çınar, G., & Memikoğlu, K. O. (2026). The Efficacy of Antibiotic Combination Therapies with Fosfomycin For Multi-Drug Resistant Gram-Negative Bacterial Infections. Ankara Üniversitesi Tıp Fakültesi Mecmuası, 79(1), 72-81. https://doi.org/10.65092/autfm.1779034

Vancouver

Haliloğlu ENÖ, Çınar G, Memikoğlu KO. The Efficacy of Antibiotic Combination Therapies with Fosfomycin For Multi-Drug Resistant Gram-Negative Bacterial Infections. Ankara Üniversitesi Tıp Fakültesi Mecmuası. 2026;79(1):72-81. doi:10.65092/autfm.1779034

BibTeX
@article{Halilolu2026,
  author = {Haliloğlu, Elif Nur Özbay and Çınar, Güle and Memikoğlu, Kemal Osman},
  title = {The Efficacy of Antibiotic Combination Therapies with Fosfomycin For Multi-Drug Resistant Gram-Negative Bacterial Infections},
  journal = {Ankara Üniversitesi Tıp Fakültesi Mecmuası},
  year = {2026},
  volume = {79},
  number = {1},
  pages = {72--81},
  doi = {10.65092/autfm.1779034}
}
Kostenlos starten →